Guia de Bulas is a medical reference app for drug leaflets, designed for professionals and patients in Brazil with full offline functionality.
The App DNA
What makes this app unique?
The app removes the connectivity dependency inherent in web-based medical databases, allowing clinicians to access critical drug information in environments where network access is unreliable.
For Medical professionals, pharmacists, nurses, and patients requiring quick, offline access to drug information.
What does it look like?
Key features
Access to full drug information leaflets without an active internet connection.
User-defined annotations and dosage reminders attached to specific drug entries.
Query medication database by brand name, generic name, or therapeutic indication.
How much does it cost?
The app utilizes an ad-supported model to monetize a free, offline-first utility for medical professionals and patients.
Velocity
Maintenance developmentperformanceopaqueShow more...
Guia de Bulas maintains a low-frequency release cadence, averaging approximately 0.18 releases per week over the observed window. Development is currently focused exclusively on stability and minor technical corrections, as evidenced by the lack of feature-rich release notes. The latest release occurred 7 days ago, following a significant gap since the previous update in May. The development trend remains strictly in the maintenance tier, with no evidence of new content or feature expansion.
Who built it?
Daniel Correia
7 apps tracked · Medical
User Sentiment
What do users think recently?
Review voice lately leans thrilled. Users appreciate the application provides a simple and practical utility that benefits both students and professionals in the field.
How are ratings & reviews evolving?
What users say, by theme
- The application provides a simple and practical utility that benefits both students and professionals in the field
2 of 2 recent reviews analyzed · limited sample
Read the full review analysisCompetition
Competitive landscape for Guia de Bulas
How's the Medical market?
Guia de Bulas holds the #163 position in the Brazilian Medical category. The lack of a significant rating count across platforms suggests a reliance on organic search discovery rather than aggressive user acquisition.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Guia de Bulas
Where is it heading?
The medical reference market is consolidating around apps that offer both offline reliability and rapid, automated drug-data updates. Guia de Bulas is currently advantaged by its offline-first architecture, but the lack of frequent updates threatens its long-term relevance for professionals who require current posology data.
- Offline-first utility remains a strong differentiator in clinical settings where network access is unreliable, securing a core professional user base.
- Maintenance-only update cadence (avg. 53 days) leaves the app vulnerable to competitors with faster drug-data refresh cycles, which erodes professional trust.
The SWOT
- Offline-first architecture removes connectivity dependencies
- Personalized note-taking creates professional switching costs
- Localized medical content expansion in Brazil
- Integration with digital prescription workflows
Next best moves
Ship a Favorites sync feature because it is a top-requested utility for professionals → increase daily active habit
+ 1 more prioritized moveThe counter-intuitive read
The offline-first design is a retention lever in…
Read the full takeSince the last report: The app has pivoted toward a localized Brazilian market strategy, with product development now prioritizing professional workflow utilities like Favorites sync over general UI updates.
Bottom line
Guia de Bulas succeeds by solving the connectivity friction inherent in clinical environments, but the maintenance-mode release cadence risks ceding ground to more active competitors. Prioritizing core utility sync would lock in the professional segment that currently relies on the offline-first advantage.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] Play Store listing, source
Report last updated